PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HEALEY ALS Platform Trial Regimen I expands to 240 participants
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
2026-05-27T    Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit
2026-05-27T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
2026-05-27T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List
2026-05-27T    Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
2026-05-27T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved